Biofrontera Net Receivables vs Total Revenue Analysis

BFRI Stock

USD 1.05 0.03 2.94%

Biofrontera financial indicator trend analysis is way more than just evaluating Biofrontera prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biofrontera is a good investment. Please check the relationship between Biofrontera Net Receivables and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofrontera. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.

Net Receivables vs Total Revenue

Net Receivables vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biofrontera Net Receivables account and Total Revenue. At this time, the significance of the direction appears to have strong relationship.

The correlation between Biofrontera's Net Receivables and Total Revenue is 0.64. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Biofrontera, assuming nothing else is changed. The correlation between historical values of Biofrontera's Net Receivables and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Biofrontera are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Net Receivables i.e., Biofrontera's Net Receivables and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.64

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Net Receivables

Total Revenue

Total revenue comprises all receipts Biofrontera generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Biofrontera's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biofrontera current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofrontera. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.The Biofrontera's current Tax Provision is estimated to increase to about 33 K, while Selling General Administrative is projected to decrease to under 34.7 M.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	1.2M	1.1M	957.6K	1.5M
Interest Income	175K	168K	193.2K	202.9K

Depreciation And Amortization Interest Income

Biofrontera fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.58	0.13	0.54	0.67	0.41	0.56	0.3	-0.73	-0.59	0.1	0.7	0.95	0.93	0.85	-0.24	0.78	0.39	0.28	-0.44	-0.71	0.63	0.6	-0.34	0.8	0.28
Short Long Term Debt Total	-0.58		0.71	-0.44	-0.98	-0.2	-0.97	-0.63	0.95	0.88	-0.59	-0.19	-0.47	-0.51	-0.36	0.43	-0.3	-0.2	-0.68	0.95	0.56	-0.69	-0.89	0.95	-0.51	-0.67
Other Current Liab	0.13	0.71		-0.09	-0.59	0.06	-0.7	-0.54	0.51	0.6	-0.73	0.42	0.24	0.22	0.36	0.46	0.4	0.15	-0.63	0.76	0.02	-0.4	-0.58	0.84	0.15	-0.64
Total Current Liabilities	0.54	-0.44	-0.09		0.53	-0.33	0.62	0.79	-0.38	-0.74	0.58	-0.02	0.61	0.44	0.29	-0.35	0.18	0.84	0.82	-0.57	0.12	0.39	0.79	-0.42	0.69	0.73
Total Stockholder Equity	0.67	-0.98	-0.59	0.53		0.17	0.95	0.63	-0.96	-0.87	0.52	0.29	0.59	0.63	0.49	-0.36	0.43	0.33	0.67	-0.93	-0.58	0.65	0.9	-0.92	0.65	0.64
Other Liab	0.41	-0.2	0.06	-0.33	0.17		0.0	-0.53	-0.42	0.02	-0.37	0.76	0.16	0.49	0.54	0.26	0.52	-0.63	-0.25	0.12	-0.73	0.62	0.0	0.05	-0.14	-0.42
Net Tangible Assets	0.56	-0.97	-0.7	0.62	0.95	0.0		0.8	-0.87	-0.96	0.75	0.03	0.5	0.44	0.25	-0.56	0.17	0.37	0.81	-0.98	-0.38	0.66	0.95	-0.95	0.56	0.83
Property Plant And Equipment Net	0.3	-0.63	-0.54	0.79	0.63	-0.53	0.8		-0.42	-0.84	0.9	-0.42	0.37	0.09	-0.11	-0.73	-0.2	0.68	0.86	-0.83	0.16	0.31	0.8	-0.72	0.51	0.98
Net Debt	-0.73	0.95	0.51	-0.38	-0.96	-0.42	-0.87	-0.42		0.78	-0.35	-0.48	-0.59	-0.72	-0.6	0.25	-0.55	-0.13	-0.52	0.82	0.75	-0.73	-0.81	0.83	-0.57	-0.46
Retained Earnings	-0.59	0.88	0.6	-0.74	-0.87	0.02	-0.96	-0.84	0.78		-0.81	0.01	-0.51	-0.43	-0.23	0.57	-0.11	-0.42	-0.87	0.91	0.27	-0.73	-0.96	0.84	-0.53	-0.88
Accounts Payable	0.1	-0.59	-0.73	0.58	0.52	-0.37	0.75	0.9	-0.35	-0.81		-0.57	0.08	-0.16	-0.37	-0.8	-0.47	0.33	0.84	-0.77	0.23	0.44	0.72	-0.7	0.14	0.96
Cash	0.7	-0.19	0.42	-0.02	0.29	0.76	0.03	-0.42	-0.48	0.01	-0.57		0.6	0.86	0.94	0.43	0.94	-0.09	-0.27	0.09	-0.81	0.38	0.08	0.08	0.43	-0.44
Non Current Assets Total	0.95	-0.47	0.24	0.61	0.59	0.16	0.5	0.37	-0.59	-0.51	0.08	0.6		0.87	0.81	-0.28	0.75	0.6	0.25	-0.4	-0.57	0.4	0.54	-0.28	0.92	0.31
Non Currrent Assets Other	0.93	-0.51	0.22	0.44	0.63	0.49	0.44	0.09	-0.72	-0.43	-0.16	0.86	0.87		0.98	0.11	0.94	0.33	0.18	-0.33	-0.76	0.53	0.51	-0.27	0.78	0.05
Other Assets	0.85	-0.36	0.36	0.29	0.49	0.54	0.25	-0.11	-0.6	-0.23	-0.37	0.94	0.81	0.98		0.28	0.99	0.24	-0.02	-0.14	-0.77	0.4	0.32	-0.11	0.71	-0.17
Long Term Debt	-0.24	0.43	0.46	-0.35	-0.36	0.26	-0.56	-0.73	0.25	0.57	-0.8	0.43	-0.28	0.11	0.28		0.36	-0.27	-0.46	0.55	-0.06	-0.31	-0.46	0.47	-0.2	-0.78
Cash And Short Term Investments	0.78	-0.3	0.4	0.18	0.43	0.52	0.17	-0.2	-0.55	-0.11	-0.47	0.94	0.75	0.94	0.99	0.36		0.21	-0.13	-0.08	-0.77	0.27	0.22	-0.06	0.68	-0.27
Net Receivables	0.39	-0.2	0.15	0.84	0.33	-0.63	0.37	0.68	-0.13	-0.42	0.33	-0.09	0.6	0.33	0.24	-0.27	0.21		0.51	-0.39	0.22	-0.12	0.49	-0.24	0.8	0.54
Common Stock Shares Outstanding	0.28	-0.68	-0.63	0.82	0.67	-0.25	0.81	0.86	-0.52	-0.87	0.84	-0.27	0.25	0.18	-0.02	-0.46	-0.13	0.51		-0.8	0.15	0.56	0.91	-0.74	0.35	0.88
Non Current Liabilities Total	-0.44	0.95	0.76	-0.57	-0.93	0.12	-0.98	-0.83	0.82	0.91	-0.77	0.09	-0.4	-0.33	-0.14	0.55	-0.08	-0.39	-0.8		0.29	-0.53	-0.91	0.98	-0.52	-0.85
Inventory	-0.71	0.56	0.02	0.12	-0.58	-0.73	-0.38	0.16	0.75	0.27	0.23	-0.81	-0.57	-0.76	-0.77	-0.06	-0.77	0.22	0.15	0.29		-0.51	-0.26	0.32	-0.42	0.14
Other Current Assets	0.63	-0.69	-0.4	0.39	0.65	0.62	0.66	0.31	-0.73	-0.73	0.44	0.38	0.4	0.53	0.4	-0.31	0.27	-0.12	0.56	-0.53	-0.51		0.71	-0.51	0.18	0.42
Other Stockholder Equity	0.6	-0.89	-0.58	0.79	0.9	0.0	0.95	0.8	-0.81	-0.96	0.72	0.08	0.54	0.51	0.32	-0.46	0.22	0.49	0.91	-0.91	-0.26	0.71		-0.85	0.59	0.82
Total Liab	-0.34	0.95	0.84	-0.42	-0.92	0.05	-0.95	-0.72	0.83	0.84	-0.7	0.08	-0.28	-0.27	-0.11	0.47	-0.06	-0.24	-0.74	0.98	0.32	-0.51	-0.85		-0.4	-0.75
Net Invested Capital	0.8	-0.51	0.15	0.69	0.65	-0.14	0.56	0.51	-0.57	-0.53	0.14	0.43	0.92	0.78	0.71	-0.2	0.68	0.8	0.35	-0.52	-0.42	0.18	0.59	-0.4		0.4
Property Plant And Equipment Gross	0.28	-0.67	-0.64	0.73	0.64	-0.42	0.83	0.98	-0.46	-0.88	0.96	-0.44	0.31	0.05	-0.17	-0.78	-0.27	0.54	0.88	-0.85	0.14	0.42	0.82	-0.75	0.4

Click cells to compare fundamentals

Biofrontera Account Relationship Matchups

Biofrontera fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	24.1M	53.2M	50.9M	27.9M	32.1M	40.7M
Other Current Liab	2.9M	9.9M	11.7M	4.6M	4.1M	6.4M
Total Current Liabilities	4.4M	13.8M	20.9M	18.1M	20.8M	15.2M
Total Stockholder Equity	5.8M	11.3M	23.9M	4.8M	5.5M	3.4M
Property Plant And Equipment Net	370K	267K	1.6M	1.7M	2.0M	2.1M
Net Debt	(8.1M)	(24.5M)	(15.9M)	4.1M	3.7M	3.8M
Retained Earnings	(41.2M)	(78.9M)	(79.5M)	(99.7M)	(89.7M)	(94.2M)
Accounts Payable	1.5M	658K	1.3M	8.9M	10.2M	10.8M
Cash	8.1M	24.5M	17.2M	1.3M	1.2M	1.1M
Non Current Assets Total	4.6M	6.8M	7.7M	4.9M	5.6M	6.4M
Non Currrent Assets Other	323K	3.1M	3.1M	482K	554.3K	526.6K
Other Assets	323K	3.1M	3.1M	1.0	1.15	1.09
Cash And Short Term Investments	8.1M	24.5M	27.8M	1.4M	1.6M	1.6M
Net Receivables	3.3M	3.8M	7.4M	5.2M	5.9M	5.4M
Common Stock Shares Outstanding	580K	855.2K	1.1M	1.5M	1.8M	1.0M
Liabilities And Stockholders Equity	24.1M	53.2M	50.9M	27.9M	32.1M	40.7M
Non Current Liabilities Total	13.9M	28.0M	6.1M	5.1M	4.5M	4.3M
Inventory	7.1M	4.5M	7.2M	10.9M	12.5M	8.8M
Other Current Assets	1.1M	13.6M	810K	5.6M	6.4M	4.7M
Other Stockholder Equity	47.0M	90.2M	103.4M	104.4M	120.1M	82.5M
Total Liab	18.3M	41.9M	27.0M	23.1M	20.8M	27.1M
Net Invested Capital	5.8M	11.3M	23.9M	8.7M	10.0M	12.7M
Property Plant And Equipment Gross	661K	673K	1.6M	2.3M	2.6M	2.8M
Total Current Assets	19.6M	46.4M	43.1M	23.1M	26.5M	34.2M
Capital Stock	8K	17K	27K	2K	2.3K	2.2K
Non Current Liabilities Other	62K	5.6M	21K	37K	33.3K	31.6K
Net Working Capital	15.2M	32.6M	22.2M	5.0M	4.5M	4.3M
Intangible Assets	3.9M	3.5M	3.0M	2.6M	2.4M	2.8M

Currently Active Assets on Macroaxis

F	Ford Motor
GM	General Motors
S	SentinelOne
GOOG	Alphabet Inc Class C
WD	Walker Dunlop

When determining whether Biofrontera offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biofrontera's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biofrontera Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biofrontera Stock:

How To Invest In Biofrontera

Details

Is Biofrontera Stock a good investment?

Details

What is Biofrontera's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofrontera. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.

You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biofrontera. If investors know Biofrontera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biofrontera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

1.16

Revenue Per Share

11.573

Quarterly Revenue Growth

0.34

Return On Assets

(0.40)

Return On Equity

(1.49)

The market value of Biofrontera is measured differently than its book value, which is the value of Biofrontera that is recorded on the company's balance sheet. Investors also form their own opinion of Biofrontera's value that differs from its market value or its book value, called intrinsic value, which is Biofrontera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biofrontera's market value can be influenced by many factors that don't directly affect Biofrontera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biofrontera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biofrontera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biofrontera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biofrontera Net Receivables vs Total Revenue Analysis

Net Receivables vs Total Revenue

Net Receivables vs Total Revenue Correlation Analysis

Correlation Coefficient

Net Receivables

Total Revenue

Biofrontera fundamental ratios Correlations

Biofrontera Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biofrontera fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 0.99	Other Assets
Property Plant And Equipment Gross	+ 0.98	Property Plant And Equipment Net
Other Assets	+ 0.98	Non Currrent Assets Other
Total Liab	+ 0.98	Non Current Liabilities Total
Property Plant And Equipment Gross	+ 0.96	Accounts Payable
Non Current Assets Total	+ 0.95	Total Assets

Non Current Liabilities Total	- 0.98	Net Tangible Assets
Total Stockholder Equity	- 0.98	Short Long Term Debt Total
Net Tangible Assets	- 0.97	Short Long Term Debt Total
Other Stockholder Equity	- 0.96	Retained Earnings
Retained Earnings	- 0.96	Net Tangible Assets
Net Debt	- 0.96	Total Stockholder Equity